Ethical Issues in HIV Vaccine Trials

Thomas Kerns

Chapter 27

So . . .

 

The Thesis position (which urges bolder action) and the Antithesis position (which urges more cautious reflection), might, despite their many disagreements, still both agree on the ultimate value of discovering a successful preventive vaccine. Both positions will probably also agree that the use of prevention measures is a much more effective way to control serious disease than the use of treatment measures. It will be better, in other words, if most people are never infected with the disease.
All the principles of human compassion do require, of course, that we make every possible effort to discover treatments for those who already suffer from the disease. But, in addition, the principles of human compassion also require that we make every possible effort to help prevent new infections in persons who are not yet infected.
Preventing a disease with a vaccine is inherently more effective than curing a disease with antibiotics or chemicals, for four reasons: a) because prevention modalities (particularly vaccines) by their very nature strengthen our innate resistance mechanisms, rather than weaken them. Treatment with modern antibiotic and chemical therapies can often weaken innate resistance to invading microbes, thereby making us ultimately more vulnerable to infection than we were before being treated. b) Preventive modalities are better because they eliminate the sufferings of sickness altogether, whereas a curative modality only shortens those sufferings (though this shortening is extremely valuable, of course, for those who have already contracted the disease). c) A preventive modality also reduces the pathogen's pool of reproduction, since the pathogen is prevented from finding other hosts. d) And finally, this in turn has the additional advantage of reducing the pathogen's opportunities for mutation toward increased virulence. Ben Franklin certainly spoke wisely when he had Poor Richard remind us that an ounce of prevention is worth a pound of cure.

 

 

The development, licensing, and aggressive use of successful vaccines for the prevention of various diseases around the world has been an enormous benefit to the public health of the world's peoples. In fact, "with the exception of safe water, no other modality, not even antibiotics, has had such a major effect on mortality reduction". We can only hope that there will someday be - hopefully sooner rather than later - a vaccine that can also help diminish the incidence of HIV infection and AIDS.
If such a successful vaccine is ever discovered, tested and licensed, its successful development will be largely due to the courage, the altruism, and the heroism of the thousands, and hundreds of thousands, of individual human beings who will have volunteered for these experiments.
There will indeed be many to admire, of course - the CEOs of the pharmaceutical companies who made the difficult judgments and who undertook the great financial risks of sponsoring lengthy and expensive basic vaccine research; the directors of governmental and intergovernmental agencies (such as WHO) who have put so much effort into making these vaccine trials come to pass; the many individual researchers who took the chance of staking their careers on years-long laboratory explorations, many of which may not have paid off; ethicists and persons sitting on ethics review boards who had to make the hard choices, amidst intense passion, hope and disappointment, to approve or deny proposed research protocols; as well as many others, too numerous to mention.
But the individual persons who volunteered for these trials must not be forgotten either. They will, after all, be the ones taking the risks with their own bodies and receiving few, if any, of the benefits. Their contributions will be at least as important as the contributions of those whose names make the headlines. They too will deserve our esteem, our admiration and our lasting gratitude.

On the last page of his famous novel, The Plague, Albert Camus has his narrator explain to the reader that

Dr Rieux resolved to compile this chronicle [of the plague], so that he should...bear witness in favor of those plague-stricken people; so that some memorial of the injustice and outrage done them might endure; and to state quite simply what we learn in time of pestilence: that there are more things to admire in men than to despise.

(For citations and references, please see the printed version of this book)


email Dr Kerns

Curriculum Vita | TK homepage | Public lectures | Jenner homepage
EVT Table of contents
EVT Introduction | EVT chapter 1 | EVT chapter 2 | EVT chapter 3
EVT chapter 4 | EVT chapter 5 | EVT chapter 6 | EVT chapter 7 | EVT chapter 8
EVT chapter 9 | EVT chapter 10 | EVT chapter 11 | EVT chapter 12 | EVT chapter 13
EVT chapter 14 | EVT chapter 15 | EVT chapter 16 | EVT chapter 17 | EVT chapter 18
EVT chapter 19 | EVT chapter 20 | EVT chapter 21 | EVT chapter 22 | EVT chapter 23
EVT chapter 24 | EVT chapter 25 | EVT chapter 26 | EVT chapter 27
EVT Appendices | EVT Bibliography | Lancet Review of EVT

© copyright Dr Tom Kerns